amantadine has been researched along with Anochlesia in 24 studies
amant: an antiviral compound consisting of an adamantane derivative chemically linked to a water-solube polyanioic matrix; structure in first source
| Excerpt | Relevance | Reference |
|---|---|---|
| "Administration of oxotremorine to mice produced centrally-mediated effects, such as catalepsy and tremor, and peripheral muscarinic actions, such as diarrhoea and lachrymation." | 7.66 | Amantadine antagonism of oxotremorine effects. ( Eshel, Y; Korczyn, AD, 1979) |
| " The drug does not possess an antidepressant action proper but activates the aggressive-defensive behaviour in experimental reserpine depression and reduces the provocation-induced aggressive behaviour in experimental haloperidol depression." | 3.66 | [Psychopharmacologic spectrum of melanostatin]. ( Klusha, VE; Kozlovskaia, MM; Svirskis, ShV; Val'dman, AV, 1980) |
| "Administration of oxotremorine to mice produced centrally-mediated effects, such as catalepsy and tremor, and peripheral muscarinic actions, such as diarrhoea and lachrymation." | 3.66 | Amantadine antagonism of oxotremorine effects. ( Eshel, Y; Korczyn, AD, 1979) |
| "The mice developed catalepsy after 3 weeks on the LCa/Mg diet." | 1.39 | Combined low calcium and lack magnesium is a risk factor for motor deficit in mice. ( Nakagawasai, O; Nemoto, W; Sato, S; Tadano, T; Tan-no, K; Taniguchi, R; Yamadera, F; Yaoita, F, 2013) |
| "THC dose-dependently induced catalepsy-like immobilization." | 1.35 | Delta 9-tetrahydrocannabinol-induced catalepsy-like immobilization is mediated by decreased 5-HT neurotransmission in the nucleus accumbens due to the action of glutamate-containing neurons. ( Egashira, N; Egawa, T; Fujiwara, M; Irie, K; Iwasaki, K; Katsurabayashi, S; Kitamura, Y; Koushi, E; Mishima, K; Nishimura, R; Orito, K; Sano, K; Takasaki, K; Uchida, N, 2008) |
| "Amantadine has also revered molindone-induced inhibition of traction response in mice." | 1.31 | Effects of amantadine on modification of dopamine dependent behaviours by molindone. ( Balsara, JJ; Chandorkar, AG; Dhaware, BS; Nandal, NV, 2000) |
| "However, in the haloperidol-induced catalepsy test the efficacy of amantadine was higher than memantine, while the opposite was true for rotation and reserpine-induced sedation indicating pharmacodynamic differences between both agents." | 1.29 | Are NMDA antagonistic properties relevant for antiparkinsonian-like activity in rats?--case of amantadine and memantine. ( Danysz, W; Dill, D; Gossel, M; Quack, G; Zajaczkowski, W, 1994) |
| "Therefore, the THC-induced catalepsy model may be useful for distinguishing between both classes of NMDA receptor antagonists." | 1.29 | Competitive NMDA antagonists enhance the catalepsy induced by delta 9-tetrahydrocannabinol in mice. ( Hasegawa, T; Kameyama, T; Kinoshita, H; Nabeshima, T; Yamamoto, I, 1994) |
| "Histamine-induced catalepsy was antagonized potently by scopolamine, an antimuscarinic drug, and partially blocked by sparteine." | 1.28 | Pharmacological characteristics of catalepsy induced by intracerebroventricular administration of histamine in mice: the importance of muscarinic step in central cholinergic neurons. ( Onodera, K; Shinoda, H, 1991) |
| "3) Amantadine was equipotent to imipramine in suppressing haloperidol-induced catalepsy in rats, but L-DOPA was without effect." | 1.27 | [Behavioral pharmacology of amantadine with special references to the effect on abnormal behavior in mice and rats]. ( Fujiwara, M; Kiyota, Y; Ohta, H; Sakurai, Y; Shibata, S; Shimazoe, T; Ueki, S, 1985) |
| "WA-335 antagonized catalepsy induced by these neuroleptics (the effect on reserpine-induced catalepsy was weakest)." | 1.26 | Influence of WA-335, a factor which blocks serotonin receptors, on neuroleptic-induced catalepsy. ( Baran, L; Maj, J; Sowińska, H, 1976) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 15 (62.50) | 18.7374 |
| 1990's | 5 (20.83) | 18.2507 |
| 2000's | 2 (8.33) | 29.6817 |
| 2010's | 2 (8.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Oliver, DW | 1 |
| Dekker, TG | 1 |
| Snyckers, FO | 1 |
| Fourie, TG | 1 |
| Thrash-Williams, B | 1 |
| Ahuja, M | 1 |
| Karuppagounder, SS | 1 |
| Uthayathas, S | 1 |
| Suppiramaniam, V | 1 |
| Dhanasekaran, M | 1 |
| Taniguchi, R | 1 |
| Nakagawasai, O | 1 |
| Tan-no, K | 1 |
| Yamadera, F | 1 |
| Nemoto, W | 1 |
| Sato, S | 1 |
| Yaoita, F | 1 |
| Tadano, T | 1 |
| Sano, K | 1 |
| Mishima, K | 1 |
| Koushi, E | 1 |
| Orito, K | 1 |
| Egashira, N | 1 |
| Irie, K | 1 |
| Takasaki, K | 1 |
| Katsurabayashi, S | 1 |
| Iwasaki, K | 1 |
| Uchida, N | 1 |
| Egawa, T | 1 |
| Kitamura, Y | 1 |
| Nishimura, R | 1 |
| Fujiwara, M | 3 |
| Val'dman, AV | 1 |
| Kozlovskaia, MM | 1 |
| Klusha, VE | 1 |
| Svirskis, ShV | 1 |
| Maj, J | 5 |
| Wesemann, W | 1 |
| Sontag, KH | 1 |
| Danysz, W | 2 |
| Gossel, M | 1 |
| Zajaczkowski, W | 1 |
| Dill, D | 1 |
| Quack, G | 1 |
| Kinoshita, H | 1 |
| Hasegawa, T | 1 |
| Kameyama, T | 1 |
| Yamamoto, I | 1 |
| Nabeshima, T | 1 |
| Hesselink, MB | 1 |
| Smolders, H | 1 |
| De Boer, AG | 1 |
| Breimer, DD | 1 |
| Dhaware, BS | 1 |
| Balsara, JJ | 1 |
| Nandal, NV | 1 |
| Chandorkar, AG | 1 |
| Eshel, Y | 1 |
| Korczyn, AD | 1 |
| Sowińska, H | 3 |
| Baran, L | 3 |
| Onodera, K | 1 |
| Shinoda, H | 1 |
| Saito, R | 1 |
| Kamiya, H | 1 |
| Ono, N | 1 |
| Sakurai, Y | 1 |
| Kiyota, Y | 1 |
| Shimazoe, T | 1 |
| Ohta, H | 1 |
| Shibata, S | 1 |
| Ueki, S | 1 |
| Zetler, G | 1 |
| Simon, P | 1 |
| Malatray, J | 1 |
| Boissier, JR | 1 |
| Papeschi, R | 2 |
| Cashin, CH | 1 |
| Sutton, S | 1 |
| Grabowska, M | 1 |
| Randrup, A | 1 |
| Sarnek, J | 1 |
2 reviews available for amantadine and Anochlesia
| Article | Year |
|---|---|
[Pharmacodynamics and pharmacokinetics of memantine].
Topics: Amantadine; Animals; Antidepressive Agents; Body Temperature; Catalepsy; Dopamine; Dyskinesia, Drug- | 1983 |
[Compounds stimulating central catecholamine receptors].
Topics: Amantadine; Amphetamine; Animals; Apomorphine; Behavior, Animal; Brain; Catalepsy; Catecholamines; C | 1973 |
22 other studies available for amantadine and Anochlesia
| Article | Year |
|---|---|
Synthesis and biological activity of D3-trishomocubyl-4-amines.
Topics: Animals; Antiparkinson Agents; Bridged-Ring Compounds; Catalepsy; Chemical Phenomena; Chemistry; Mal | 1991 |
Assessment of therapeutic potential of amantadine in methamphetamine induced neurotoxicity.
Topics: Amantadine; Animals; Behavior, Animal; Catalepsy; Dopamine; Male; Methamphetamine; Mice; Mice, Inbre | 2013 |
Combined low calcium and lack magnesium is a risk factor for motor deficit in mice.
Topics: Amantadine; Animals; Antiparkinson Agents; Benserazide; Bromocriptine; Calcium; Catalepsy; Dopamine | 2013 |
Delta 9-tetrahydrocannabinol-induced catalepsy-like immobilization is mediated by decreased 5-HT neurotransmission in the nucleus accumbens due to the action of glutamate-containing neurons.
Topics: Acoustic Stimulation; Amantadine; Animals; Catalepsy; Dizocilpine Maleate; Dopamine Agents; Dronabin | 2008 |
[Psychopharmacologic spectrum of melanostatin].
Topics: Aggression; Amantadine; Animals; Behavior, Animal; Biogenic Amines; Brain Chemistry; Catalepsy; Cats | 1980 |
[Effect of memantine on central neurotransmitter systems. Review of the results].
Topics: Acetylcholine; Amantadine; Animals; Blood Pressure; Catalepsy; Central Nervous System; gamma-Aminobu | 1982 |
Are NMDA antagonistic properties relevant for antiparkinsonian-like activity in rats?--case of amantadine and memantine.
Topics: Amantadine; Animals; Catalepsy; Dizocilpine Maleate; Locomotion; Male; Memantine; N-Methylaspartate; | 1994 |
Competitive NMDA antagonists enhance the catalepsy induced by delta 9-tetrahydrocannabinol in mice.
Topics: 2-Amino-5-phosphonovalerate; 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Amantadine; | 1994 |
Modifications of the behavioral profile of non-competitive NMDA receptor antagonists, memantine, amantadine and (+)MK-801 after chronic administration.
Topics: Amantadine; Animals; Ataxia; Avoidance Learning; Behavior, Animal; Catalepsy; Dizocilpine Maleate; D | 1999 |
Effects of amantadine on modification of dopamine dependent behaviours by molindone.
Topics: Amantadine; Animals; Behavior, Animal; Blepharoptosis; Catalepsy; Disease Models, Animal; Dopamine; | 2000 |
Amantadine antagonism of oxotremorine effects.
Topics: Amantadine; Animals; Catalepsy; Diarrhea; Drug Antagonism; Humans; Male; Mice; Oxotremorine; Tears; | 1979 |
Influence of WA-335, a factor which blocks serotonin receptors, on neuroleptic-induced catalepsy.
Topics: Amantadine; Animals; Anthracenes; Catalepsy; Drug Synergism; Female; Humans; Levodopa; Male; Physost | 1976 |
Pharmacological characteristics of catalepsy induced by intracerebroventricular administration of histamine in mice: the importance of muscarinic step in central cholinergic neurons.
Topics: Amantadine; Animals; Atropine; Biperiden; Bromocriptine; Catalepsy; Histamine; Injections, Intravent | 1991 |
The effect of neurotransmitters on cataleptic behavior induced by PG D2 in rats.
Topics: Acetylcholine; Amantadine; Animals; Apomorphine; Catalepsy; Dopamine; Fenclonine; Injections, Intrav | 1987 |
[Behavioral pharmacology of amantadine with special references to the effect on abnormal behavior in mice and rats].
Topics: Aggression; Amantadine; Animals; Behavior, Animal; Catalepsy; Central Nervous System; Dronabinol; Ha | 1985 |
Anticataleptic actions of amantadine hydrochloride.
Topics: Amantadine; Animals; Aporphines; Body Temperature; Catalepsy; Central Nervous System; Drug Antagonis | 1970 |
Antagonism by amantadine of prochlorpemazine-induced catalepsy.
Topics: Amantadine; Animals; Barbiturates; Behavior, Animal; Catalepsy; Humans; Mice; Parkinson Disease; Pen | 1970 |
Amantadine may stimulate dopamine and noradrenaline receptors.
Topics: Amantadine; Animals; Behavior, Animal; Body Temperature; Brain; Catalepsy; Catecholamines; Dopamine; | 1974 |
The effect of anti-Parkinson drugs on catalepsy induced by -methyl-p-tyrosine in rats pretreated with intraventricular 6-hydroxydopamine.
Topics: Amantadine; Amphetamine; Animals; Antiparkinson Agents; Apomorphine; Benserazide; Benztropine; Brain | 1973 |
Catalepsy, sedation and hypothermia induced by alpha-methyl-p-tyrosine in the rat. An ideal tool for screening of drugs active on central catecholaminergic receptors.
Topics: Amantadine; Animals; Apomorphine; Behavior, Animal; Body Temperature; Brain Chemistry; Catalepsy; De | 1973 |
Pharmacological effects of 1,3-dimethyl-5-aminoadamantane, a new adamantane derivative.
Topics: Amantadine; Animals; Apomorphine; Blood Pressure; Body Temperature; Brain Chemistry; Catalepsy; Chlo | 1974 |
The effect of amantadine on motor activity and catalepsy in rats.
Topics: Amantadine; Animals; Brain; Catalepsy; Catecholamines; Chlorpromazine; Cocaine; Desipramine; Dihydro | 1972 |